Introduction Emma Walmsley, the CEO of GlaxoSmithKline (GSK), represents a significant force in the pharmaceutical industry. Since taking on the role in April 2017, she has been instrumental in guiding the company through pivotal changes and challenges, especially in light of the ongoing COVID-19 pandemic. Her leadership style and strategic decisions have made her a